vJ0{ּo ʢL l+XI& `qVu@"HgrX:wuu.zn8z0p ֳWUlIV Kk[J~]ƇI~Ϛ,Yݮ uqɦgh}fgiv6jﱆo rJ5F:D3A]h<u9 ZgtUɏм_uZ`6-"KcĆZubwz++'ɠ&ol45ZZdEs]ȂQ:^M..nl,Vq*5M>}-fVCq=·B 뜰96bԟW >!>CD_j J`=% = W6S)BK@ƠQV֋ ڿE``P5EPX)+5qB:u/ .ԫl#L3P}e]CVV@hMIPt۶!'b:/^[Ӥ|FyFw^b3m,?FSuGqiv;7 x&_.`F,(n0]G-ygm ڋ" l8ͰՂޑQdDq/zq@rE(\&(S]ɚiTi9MQAR| ;X/-ng%h(cE ZMEQ1",Mm|>i\ݤfKT:P T*3rL<]OR#,ЕXGr @,H#'4m>0Nm29^5;5l^ˤ mh`|񈋌1QMJrLT@x˹[R]p%{]}`{ U4P _r_~Ti(%3l3&E"8Fݎ=o/+ʠF;DNbPr6l%'T3rBO_Q,EX&]^K ኾ`s ׊R(ExYg/UZjE}22u`mzjP' fPЍD?U;5ːTTe؄:{44gi o_W4iXH @jq JҡA:ц6I >*RP6s~G2C:"BXo1h%۰җg $tzU:?DdUvWu~ eE397ʏj m$B z0m.E op/U(ꀈAvZ¬t63Y_^lhe@v\_T1ۨ c0#x 2#v#t+u}`lR}+ZS[=c]_*guEtX\7R8SLN(QqVA/o^B%a#&Ca ITLNh{ sPv8RVTi Z@d_{#Zwaq]>4 Eشq:, 昻O:JԺ n@@[=p- .xfۄ!-*Q=+Ѫ`j-w.t*A8/`B=i}N8ԟY׆#40?TTy&/R3>maW˰a7,\ԝmmNm׋:4ק[/IrKdBђF6^]Ur}0ɯAQyhn 4@;W,2bJ-YqɧjaklRLUF}~6-ݦ0Ya@e0STrR".iCsw`0sH=`܊mʻd5(u?@P7'zLjX4C `|,tM F<ϟOexdni-`iܿK?һx~#G0FA (H| U7RROSm6qBx̬[}Z[U廠#Յ:"=}FM(nGl8 fI(@3j4ڏ\<څUaj=Q V B^)LaRĆٔsJ爭PZg7Jzd@/o 8pnzTb,5`0$-= B`d$tDΈ[ CCIfi~& JlC t!;C#3%$xxA9uuUjH+nR u/rb@ZrO^J@::}٦j@j:׀#X ]4d{PfUw\egSTaBQňZf6A #Cq|}[/{Зx+_WaGt,hlĎZZ;`^áppa^pb 5Qnj4r~0~,J5TQS!)IPm:*$$@?OD@HBbE9ܓJIoVA3"lMigmF Gzd%[)c1M.-'Om9dulU1jO@ OcӺ$hat";,'.ZMjQ4؆siƘ}PQ<.Xp='3tz)[-uu<8,}EgB@$"~v i|=x9T,kd>6aTZsѻ$~Jfwͮ喰O@d VXS04:aaR-R'@vWpK/ w@1'UX$!.ii7Q&Lr6.}MX]< ڷG!6$f]^H _B:24?(VsXؽ8/UϫTs!3sf';PC}e^ISYRL<esun*SDA9z8[k3嶐kb‘DȧB GΫv ka{lM^Z"Giat9j>0'x-|&xG?5'dGX_fHvP \WLt|IPRБ"b+vālK.9(Ptј= _-U`!]W+:Z+ >-h zm_]&y۳Xrg}>}6bMkiSrި&&@-Wqn/k Z#ą[?$V ZBw4D -$c90f&--(<R?斦]nP,* 5A[qI6CbDurH2MSbP@wR8f^zd:Cn<psIuVkhQgtFQ] xf2EQlbLS{#AY7rQ ^h+1{$m2C[ⷳ2 眀/%]PK-~ xV1fOeXeI" 2(Ex@ z)m k6 qܬc5@HBA3'P@slBc;>; `D8,`ѵ\' L/ѕ@,@)U$%r(F08xďlFOC>W{E P'x%TnʫtU0ֶ%&%u )>#&bx D]ǂCډ|L)1H-ı2r`䋈(0x* Z[-Q^fjmϏ {aTr geq-VO2˸a&^YƵ؇z\YƵ^zKR>"R9..-hah xaxhshmxi"@Ҵj4%=4hѡ D3drJ1q:>Q]rC fɿkc9^]?+ͦfi-'N vxB??ZW?QHRDt.E#1QePP;Lk3o5Nk,6h4?;ߜkݞk >.vȧMth9?wvpK,]쬐}b\gGz+8K~X]]=`Yo\YDgIOKXVB AxuQ8^4ã r;޶O{͛vܽFS?lON:V7VyztPbw _'x:yrtϵn߮6y=}Oo6/NSg"FuM7.~hyvܑəGkzyupT/Zܶw֑}zrj߾߻86.mEk1~\X{X̥%k2Y>8l|ۭXyspVvNܬ~P_|}RZ[U la {}.TƷApo|} \yc~qhl4>UOmXzc5V-Y]pNDm;o7'Ճa y|/+g?׀rv:뽽owwgazsr.[3W_Q?uͻJv|w?{׋'\{ fm置ޭus\꭮[߯Aݼuxytwf/kX׽Oӛl vk|[y 8_=oZ`p:@P\_~:_]?Y7G$z}۸Yn4tb/{۳ow.w߰Ag~3HETgK+~rvUwv9BAQdr_f nj*u^,糸2+^%*]Kd96( ooyWT&?ōյU>#N:JJgщ,M:*)lWf CK)Wp/~!fFEة>QdcDF5۱M2Acl61r$}|i-GIxq'F)n#5# MIKx>'9R^no,,-.nj^0u[`+Vn-Tt,$3N~x@TVC\|zfE@Az>X\6x?pqYڜ&dZϓ=RᐯHbCQ|*(? vIa%'@Nd,%c9!Ϋԫ6H}yQCH()Em6f#bx^|bzpho֡liJQ(ƻ-QdEj-8JV(B ?$Z2+iQi[K!i3"ovE44(ƞRj?)sʳC!!7ʔV4Pb3rSqQ"wrIrϛ1A"FDӢmY%2XN:ucj `Gm>%x\Q=I(;j̟8!K]ifH:u,)58 |S75ۗ$B a@1d#mMt126ߪ[mk*}̀0Gʯ)sxÁ7b@r( J ̠APGu~PJv;#v}dK#Vkh+v@78~CSF%'FJ,]̎ H3qtXSbM `^b8<֘M&q.JMlv45TT ҞI`b&kj\C ӈV#[ MlP5]Ƭ\n䳫4 Hhe "y.J^kХb@"6_C >D9a9sT Fyk9-bBU ["A% [Zff|&(kim` O#p}pҡ {hxTSc0q69TN phA8 G'MWODr>Vaj#ILO+&DjA2T֩`Vӱi$?>˹FȕSQ{GHH@u"$odM5IP1|+>?o\ 'ۨntzJxhHmoO0i?;ޡ-m_hC\InGH }[ǐHަzz9>MFSXL9!Œ&O`#CE pUZjT16dyոv{a(PqAenYeCI1!p S9, YuDKͦpb6$GJK&H2KZ ~D)&zQǡ24_9*F6aqxޔaFfr^Ci2@L%* J,o{1XjU]@~+Dxx5Жؤet3;l~+O4d).~V$ , A#F)ՂGB"!w%nz:YB#wlae*, =䭉59ƻ6q)Oo* 43&>Zw$)n7v8 v>츖;@nkc1 -0T[L■ JbHv lԌ6 O|&Lwmh1|9 LKAG $L|ZKSTwZ b*:s̸Iˌ,SL)\)~\&wK>sԐv"1r6lFqօXB=u VH'- { \?[_s*.};zsZ]o9{R7ޚa$ZNUGNTF2H] Ff# 6bzQSڡ) n8LX _Ovd(2be u1H~Xx#oA,epLU, S9v;cpa8fipLF4Tƈ`x[:viҩ x5}Rgs r'eL#"?䘞7_9q|\Jwd6X|¹.Ko$LjAlgӌ=y'ʕSJ˖٫- L\y34H5&V*ju`j}j?G[¦H#b ed1m0fT0E.=^O< @H"wlgLKZPTU(t' tT<լO,A3/O^e޾Us 9Oy_#,tu )k'op],%0IZWA$җ&MM"j3eۃFe/ʰ.جPzI:4F][$෶ӳ(xQwFceGZgՋf#RaM>j(Z`)Vw!_(8>E(F~mh  lDuy.gѴ?K󜼞gZzEAQYZim9:~N ԡw6#ݝ8{\<D|2.*WԿR!sAMhۍD7QbB=( F訹$_7T,uVs'a&2gi}$8xYzSG䭷 яwKGfi A@E|Z.L+oӼx<;4 ?񚺩ݨEpz{q/ퟟ\&w;ىzg$^]Gt#Tߢ뿨W$s@cGycj ,P b=>tV7&;]t"5Mb~ XYʷO7l0X 2кyRECBEAyG;w@F0Ht~DhoLNQO/[e̓Pqkwi0lHwc1B@%눣!K_+oݣ+ my- hg"vvv˚ HWJ<_@)FE+dtJ.tfA![D:g6c@M%lOa\^66OOgoha԰ADTGi(4Y ^R$7acإo1`ϝe, 2hI<;KBw"= T[B2rI$ [Hzr)] _!RS7?@I<~h8:^X$hjTr=BL?GUrf i)4ygqsRE֌;G􁼵ßux㏩kZ0rA#^9hDq<> jü\ܑyya|x|x|x|x|8<<<<<<< ]"b/Pg.[FxB:QprŞ'S~d%R<  ,r@*O arNE Vb xёpxcPɦO#,PkEu4DR#[Yq xR;/⸀X轩bw4>>?o\ 'ۈ +bx)&ìn_hC\InGBoӃoBx[ǐHfw<1!d45\|͹L8djBiJ3F>IʾgɱZb|ta+tZU.׺9!Q'y^sb8Gi4r_^_][M&U] a.̮G\ mWzt܎)'tVd=U1C$p&(d; y՗ˍC`]iby/)(?~hCRwesޡ6Ems/D0o21&'8f[j/G*ZC;ƉyML Łʠ9.r/| OX:3cvI[Dv?Uö4 nshUoh%tO _j("#gh {l;ET*{¤h ̥qRiFaǷ R7M[g[#g.i1M)k.=iz ?axh9GcSS> ss6c>A?*cf9:~[nbDLZ1b>~!~}h3;ulGI 71ڏnP<hHQH)+ S.ړϺ:H}~oI{oM;Lv^ [j4 !!*# # \LK;Ć)=+_`/4OF~_ű_`v31Csqa$L#"(ѣjD8vwqya8F#o&cY3 3fW~kpbi:bwGiwCːŻݿw; :00W sǃݭ;]mj$m7c٤$F9%Qx .<L@&LK3v";PZYU+k 4ZTԝSW-.ѷ"o,VWԥZ3 EnmeɆ4 z Dш )28L'x ʽfIm쬉lѽL#hc90-`/ ʲolnWN55bQ9U>Nuܥ3ހfӷ&Υ6nOyO!D˶cuqcum=I4B:(-/ ICkiKk@aٳ(sX?ˆ^+W/A4>hh@-%\2Бa21.Q[E -ИN7j(}={'~j1=rTkEv1>Ϥcq&G?.CBb9>(+9ajIZ8qeyEݔlГ4/kY$txZiL-椮H.oR:4ڀ(%4DN.~9X߿x| ^؛a,{$]x\V~vO!;5Qenʿ؍,?pVe2r@;a.[9\*4 Kp8i:V]U" N6j75C¨3$笴C6wznDzʱg;_<-wwƽb_:/uO 1?XnR*V _ {g?"4="ed.OK?RsOٹSv);SveGeיKO;w睻ysw޹;ܝw;w睻ysw޹;ܝw;w睻ysw޹;ܝw;w;oVnt¸4:eX(`@>wZݸ7~az'탯k֙h~?:ݽ]j|h,Unկ]t^+Ջgm _.ֽ{Gz+8K~X]]=`Yo\YtCldeęW{;;W&>+S^T|QڊhJxo^,RlHyC@{w]?aTx_ҏ:%7;9/>(4ӪW_EP~IH}vZpJBkZyWM[W W- Ei.( 8b*2"]"6;f[+lԲ"ɗ;rRU~{ع5ɞCk2:BM x!y` F]&X:{a4_zbOs𼚌CHHZ45IΉS}ɶ 6&9޳N$Blt͟ЅW\ْ '=Kvd .z]z}r4OE?N)JR p*Vq!Gimzȑ$۱c3%/NiL΄)JE);Ex7Կ=$%HE~lmcJ]$AJ:(Hy<2$M7"< T 9a>$9twqO??/w]cV3[7>Ykon+i4AݟVͷ{?[o>[$о=p!%P.yY8{?l2l{\SX)Hn>^ hr^QjaMm-A~n̟Ά~{6ZͥnCvvdvssW*Fu nDTP(тt:Й(>}Q9R= Iwy_Թ6|PĹU=LټK6g٫WXk}KX^MgQ#ٌ)Ci`9Iu(rQɤQ*w49t?SNɪEFV;ϳ`NYJ.Bx?,-D h`P 4=z# \j>FuBE|ɚ!~@_t?L 3cwLTß\E_&oz֡ ?t򰂃{BI|CN]0(.E9Jt~\;^]kͷwwJb=묒Ϊuժ**Z?IT@< &ci y9ӳq죘S'ŚsiPP[?aӴ74v''Öu7la't o\î[X. ^vIn7;v{躢i7uI}ACO+t$D0F8t ~0iw^WþE6^btZßCamH0R,`:leCҳ7kZGi/3u ?_,/JN 6Y-x{5^n=;f*Aǯ~O7+Ȕ`(R,*nݴD\R"-&wLA;T))K$[Wd%ʧ_ÜOf1ExÚfTIڦ*Gt Ǣ'E2"&]m~/7%S1ha_A@{rFS[#5 ;ZAfuqiucc¨KxU=z{KEsy~E>\~Z?Džwgo|<H WRH p7o:Nw[e?'ͤ(!2FA:f7*:ϴ


Vitamin E Supplements: Good in Theory, but Is the Theory Good?

E. Robert Greenberg, MD

Ann Intern Med. 2005;142:000-000.

Much of the U.S. public has a deep, and seemingly unshakable, faith in the health benefits of nutritional supplements (1). Use of these products has increased so rapidly in recent years that a third of all adults, and half of those older than 55 years of age, report taking at least 1 supplement daily (2). The shelves of pharmacies, grocery stores, and "nutrition centers" are well stocked with a dazzling variety of nutritional supplements, and for sound business reasons; supplements accounted for an estimated $18.8 billion in sales in the United States in 2003 alone (3). Many of these supplements are promoted to the public as "antioxidants," a fuzzily defined category that includes vitamins C and E, some carotenoids, and many other phytochemicals and plant extracts. Vitamin E is the most widely used of the individual products, and it is taken daily as a specific supplement (usually containing 400 IU of -tocopherol) by 22% of U.S. adults older than 55 years of age (2).

The touted benefit of antioxidants is prevention of the major chronic diseases that affect modern adults. Belief in the preventive value of antioxidants rests largely on 2 bodies of evidence. The first is epidemiologic observation, which has been interpreted as showing a decreased risk for disease among persons who consume relatively greater amounts of antioxidants in their diets or as supplements (4). The second is laboratory experiment, which has implicated oxidative chemical processes in the pathogenesis of such conditions including as atherosclerotic cardiovascular disease, cancer, neurodegenerative diseases, and chronic lung disease (5, 6). Clinical trials of antioxidant supplements have not shown a clear benefit from taking these agents. Nevertheless, they continue to be widely used, even by physicians (7, 8). Many doctors may share the view of a cardiology researcher who told me his reason for taking vitamin E: It won't hurt and might help, so why not take it?

But could antioxidant supplements actually be harmful? Two large clinical trials reported in the 1990s showed a statistically significant increase in risk for death among participants (mostly men with a history of heavy smoking) who received -carotene, an agent previously thought to be nearly free of serious toxicity (9, 10). More recently, the authors of a meta-analysis of clinical trials of antioxidant supplements and gastrointestinal cancer concluded that random assignment to supplements may have increased overall mortality (11). And now, in this issue, Miller and colleagues (12) report the results of a carefully conducted meta-analysis of clinical trials of vitamin E supplementation. They conclude that high doses of this agent increase the risk for death. Their meta-analysis involved data from 19 randomized trials, which recorded 12 504 deaths. Overall, being randomly assigned to receive vitamin E had no effect, either positive or negative. However, the data suggested a decreased risk for death associated with vitamin E in trials that used lower doses (<400 IU) and showed a statistically significant trend toward increased risk at doses of 400 IU and above.

The finding of possible harm with higher doses of vitamin E is surprising and has serious implications for the tens of millions of people who regularly use vitamin E supplements. Yet, how firm is the conclusion that the risk for death is increased? The wide range of vitamin E doses used in the various trials and the large number of study participants and deaths enabled detection of possible dose-related health effects that any single study could not identify and previous reports from meta-analyses have not addressed. Although Miller and colleagues excluded 17 trials from their meta-analysis, all were relatively small studies, and I doubt that inclusion of their data would have materially altered the principal conclusions of the report. However, I am not totally convinced that the authors have isolated the effects of vitamin E from those of other supplements, since 10 of the 19 trials included in the meta-analysis involved provision of vitamin E together with other nutritional supplements. Of particular concern, most of the evidence for an elevated mortality risk at high doses of vitamin E comes from 2 trials (13, 14) that administered vitamin E together with -carotene, a supplement previously associated with an increased risk for death. Miller and colleagues controlled for the possible effect of other supplements (apparently considered together, not as separate agents). Likewise, much of the data on low doses of vitamin E comes from trials (15, 16) of multiple vitamin and mineral supplements in Chinese populations whose nutritional status and causes of mortality differed profoundly from those of the North American and European participants in the other trials. Miller and colleagues acknowledge the difficulty of drawing broad inferences based on results from poorly nourished populations. Nevertheless, one cannot fully discount the possibility that the effects of specific supplements, nutritional status, or the conjoint effects of these factors underlie at least part of the dose--response relationship observed between vitamin E and mortality. Thus, while Miller and colleagues' report provides intriguing evidence suggesting that higher doses of vitamin E cause death, the case is not ironclad.

The lack of a benefit associated with vitamin E supplements in this meta-analysis accords with the published results of individual trials and previous meta-analyses. Despite my uncertainty about the finding of harm in this meta-analysis, I fully agree with the authors' conclusion that high-dose vitamin E supplementation is unjustified. Ample evidence indicates that taking high-dose vitamin E in later adult life (when most use of vitamins currently occurs) has no favorable health effects, and Miller and colleagues' meta-analysis raises the possibility of harm. Thus, our message to the public must be clear on this point: Vitamin E supplements won't help, and might harm, so save your money. However, many users of nutritional supplements report that they would continue to take the supplements even if they were shown to be ineffective in scientific clinical studies (1), so basing our advice simply on evidence of no benefit may not have much immediate effect.

The public's faith in vitamin E, and in antioxidants generally, reflects the strong belief of scientists and health professionals in the theory that exogenous antioxidants prevent chronic diseases. Ten years have passed since publication of the first large trial showing that vitamin E supplementation had no effect in preventing cancer and cardiovascular disease (9), and subsequent trials have repeatedly confirmed this result. The story is similar for other presumed antioxidants, such as -carotene and vitamin C. Yet the notion that consumption of antioxidants in diet and supplements can prevent disease appears to have drawn strength, rather than been weakened, by contrary results from clinical trials. Investigators have called attention to isolated findings of possible antioxidant benefits for subgroups of trial participants, or for secondary end points, when the overall results of a trial were clearly null. After -carotene, initially viewed as an extremely potent antioxidant, was shown to be harmful in clinical trials (9, 10), some scientists opined that the result represented a pro-oxidant property of the agent under certain conditions; thus, they made the seemingly perverse outcome fit the antioxidant theory. Meanwhile, research based on the antioxidant theory continues apace; a recent search of the 2004 National Institutes of Health funding database produced more than 700 hits for the term antioxidant. Most funded studies are basic research, but they include many clinical trials testing vitamin E supplements in tens of thousands of patients, with dosages ranging from 400 to 2000 IU/d, for prevention of a variety of conditions such as dementia, heart disease, and prostate cancer. These research projects have all passed a rigorous peer review, and I do not question the scientific merit of any one of them. But isn't it past the time for the scientific and public health communities to loosen their ties to a theory that lacks predictive ability for human disease?

Author and Article Information

From Dartmouth Medical School, Hanover, NH 03755-1404.

Disclosure: The author led the research group that conducted one of the trials whose data are included in Miller and colleagues' meta-analysis, and provided the unpublished data to the authors of that report.

Potential Financial Conflicts of Interest: None disclosed.

Current Author Address: E. Robert Greenberg, MD, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North M4-B402, Seattle, WA 98109-1024; e-mail, E.Robert.Greenberg@dartmouth.edu.


1. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE. Americans' views on the use and regulation of dietary supplements. Arch Intern Med. 2001;161:805-10. [PMID: 11268222]

2. Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc. 2004;104:942-50. [PMID: 15175592]

3. Supplement Business Report. Nutrition Business Journal. San Diego, CA; 2003.

4. Stanner SA, Hughes J, Kelly CN, Buttriss J. A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr. 2004;7:407-22. [PMID: 15153272]

5. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239-47. [PMID: 11089981]

6. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004;44:239-67. [PMID: 14744246]

7. Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med. 2002;162:1472-6. [PMID: 12090883]

8. Frank E, Bendich A, Denniston M. Use of vitamin-mineral supplements by female physicians in the United States. Am J Clin Nutr. 2000;72:969-75. [PMID: 11010939]

9. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330:1029-35. [PMID: 8127329]

10. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-5. [PMID: 8602180]

11. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet. 2004;364:1219-28. [PMID: 15464182]

12. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LA, Guallar E. Meta-analysis: high-dosage vitamin e supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:000-000.

13. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23-33. [PMID: 12114037]

14. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439-52. [PMID: 11594943]

15. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993;85:1483-92. [PMID: 8360931]

16. Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst. 1993;85:1492-8. [PMID: 8360932]

vJ0{ּo @lVM @5ݪH)R]@箮ՅO G.:A~^- }iz[\I4߯˶PB5I~7Y%KuYޖ^>"aU5n=uorU.eRfJ VGшG*y&$ahQNKJΣȫ%ӶZW`Wv"v;l9KKEݕs]r_֮#(N/bE=mȽ5;8{ڧbփL\T4xZ8uIMÀt 2}ھ\,Ђ D}@!1g O+U@28'jW(PL3loar<3pMY*<ǓuxJ~E@:ڧղ|47XWϤ7ᱴixZMjeKK7 +\9)wESt+WWkNAlҗ.m] ۝`7ф0 k&@%е(e ְqpYX}>,W.P# whRK|pF()EfБlG z%6.*BNC˴Iݎw:yeUS݂ ?haE;dw3>>1o-|k;- c+FiUxb3Dta/AQAa~ݣ[2rޗpUi|a:;"$ d Ehe,Ä"gς Bi>{rZ7/t[ΨSZ`@_R6´=%W5ThlŊ ZFIڔ4uOmr*6왻]11M1i;oe|%V<^9aC$9_^xm@?V ̮isہg`8n&C ["wF؆8./Ȇ [-EnhHF. #]nR^r>{(=; y01f;e}B T(9O["F7CQ@Nز@`8a m?{Kp p%ZUx|6>Hf5XĎ, }N7r%LFчm2}i]"_Glz$w) )S:ՂTp $ -E)v֤ @.hLt-)¹W./ׯrrZׅ03BCa,eb_Pjߥ'[3~w߬8: hǠ}8HE<5Bdž4A9x -Xoz ?VO7Dp8(JXǁߔTQ۴O-M'U׊ʊ(fE=3 ]2!άFV&i_>m*$4@uz$ER9=S @@G9-5>JP,oD5tMF%9OЈiZ>(E!`\"H戩%R8},ȅX[{-wG-Pkh:+@XdELPَ=:!,nQ*§BgX6 %FAwC~ydFP72BPO $7 l+"F|\Qƫm.~dиVϬ^CqQv zCBJ֡@+t(`JbE@\iN#ω:JZ•`r2Օy6|Me)Пӄj${Zװ}]P Yzv2VۄZ--)C)R)-Ԗx7]V|E}M +eAū% ( ~@2#t>#%opn$u;]u$׀4V yBc^铫 oZ/S9U#ɜSF:LˋPؖHX;Eє,'K˔ qlOkM +%!W'/u~&箏0PYEC %UoHUۜZ:v1c"HX$cXBNnqoUDx {B jWƀm jFNp!=͢ښj\T -`jrQL`*Eu0KF19- !H RǟuxvRU+Q_DZ= #CqZfݦM᫧N* uRKl%+TC]4d/Yȃt2(&Dv0L!IxR>rV2F2 A p@0!P%xRjk%I$2`CA,)Ev+Ijq=5Ef\faJjI^Sk F=캗 Й-%%732&"G5?(dBSʙ}^zVJqq%1 @O`'IRɪ$n<εdIF-LcTo\!X7%hbi16ʳ6&~Kf:blʇE&+Ql᭕Œ3L&/ҰF2hE J˻#hx+-S_C֢_D* VSb;0}zn ;S{{TNeL)S>]V6GqTLn-o@-e.8 8=h'R0aOYPj2hKOYgL]IZDA(o+TFaY4$WP`oLeQ|F(Vi X jM:JxZ*E6/[_OL)y#M)ώ^=1fȉp㹥'Mbi0ɩEL=9l{9!1=y0>+Rc^0̣4+ jU)jXc29!U )S2#P. |]Az?;{\O/C)[ = &OPe}g Fk !mo!(-&Ƙ_S$2TE[pSM>o`7p[#Kz3 ((s]8/3ޚh>F YsM]ǭ%تwS&֐p;,-!d==dg'J{╕1D*SCc]-;+]=?TK']Z{w q©H$:S)Kb#LS &FL*8d 6ťtJ?{=W$S"W:Gt**|`R2Kwb i: . FHZ(fNq}P\ P{0Dr(:\Ϙ[ dF+DhvDvף*9&ʳf;"9vj唚À|mMh5L<䣍7j ߨ?iJ$9L 0GVы-DG >[m Bx;x _Җ&6{]n,}/bW_r2br&qѾPܲK kx[/ @a=?P]`O}m+Rr~ݑYHY 1Z5ٚ>#pB+J$?]#={jqK4ȧtH@m9zUR]~+v% IД[C1˕2 4{Di=6x39yKjl87a+:"!KOMO'ƛ1 bN/' =E"W;<%kW2ÿkv(!-'..E(-iCQTe)`׹k2A2ЦVӗĬ_]+[`K3@5yaK V\&jqgpEpivJy*djƹ7k^ ]9~e QH h聾l.%3~z|rRt4,ӓqA dֹL`8. !,A6 QlAa({$Wz ظkByb1av=~Wu<%@%#Z6(]7ظr}6bMkiSrި&&@-FWqn?k Z#ązܭ~WNjCVufkq߭!RJVzӬZGAmf]+ԯunV# z ]=F\nL*7bFaAc%AJMMIˬk!?V=q8 Qc A IXN_2i[J Dҍ/##0WgϞw=\ `ʂL;5]ڊ۬!NJT͸ Y(*.U体#7lEsFOUw42ybjS"A!Y˄sN YTlKޥJ?jZX?`Cg2X,2v$R_Ux"Ǝ}t=~e k6 qܬc5@xHBA3'P@slBc;>; `D8,`ѵ\' L/ѕ@,@)U$%r(F08xďlEOC>W{I P'x%TnʫtU0+}KLJRʇ} G- 0T<5 aQc1Zcev%PLa=y$=Fǀȩ&顽^XM@"/_!WjΉp$y0'`g3-N6Zo3FYЙ~+aW겲0^\Acf`"ұHȒZYe{{*ЃeV+FAd1k2+-eU#,D=fr٨peg-ϡ$r F5Kmi[DY zF b=oO<#39ri\ лev[ɱЃϱmi3,Z*,qh-'0.=gj h[Yr $hd\XT@N+(n"2(n0 r ]֥͒ Zrv1 gc*bY$i-U٪:cU'7S7E0Ji$fN57tHIGē`Gjގ)y_1YWuh =y;貣?J@!b5Z~/;J'7P LbXui9!z̪?_jϟoݔ4h 'ϓet#]6q*8q2 h\2DFi(DsJbl7G.',~Ac>lxk4JTzʪ2ځ^"~]~>x.K\$ r£6`D(LTKɵr`LZeV㣢1eQ 9FU|pQ^reX/kfzg\/O2ϸ6|Y/bcIgXDJ;ԕ M; O; osmMoM 1 }S[`s9@w`umPM"~4>zlu[N)@ǧ>"kBn,6*0ԌrZK ],P{XYwW$g| :UעɑȘ2!(Bf귚4M7͏7:=xy۳77ʧN|j|дOƞxn矏*Qݕj Ow}Ѹhg}iܯkkkg=_[W: ӽ]?k,i J(!(Vn:?6 xxtW?4zIwyn4Z޻O_|lT>;pt넭cu7~ŭ wB4ZQkm>7NG7_\^&Lgm;{n|zqqW?ll}c7ݸr#;-ד34֗7_m#dcp;}wyZ=Zm~]7Ecq=RaoX̕k*Y=8l|ۭXyspz;on>}}{r/>^~0=_Exb}^Z087 {o/wXko4Olm~v82VgszzKvw7ӟ?+fvΛI2X?*!oOq:PNֳ >[x8 כ3gmꞹ AZ'߼[_ng7}}~qANn7joݸx՟JmŻu}?oZZ˗G7{Eݴ\cZ}>޼`t^ط{_[N߸{?vۇKB~z `~sD¯Zݷ͛FC'F+ߍXJez]nѮWg/oYNEfZ*ev&R?YѡUJ΢|>,QoXYNҵOn"aAKxuIax\\[X3┪ӫĬ~VҴx~i0$rh -)'b;kTdE:Fdt-mXlLl k0@5`ChT Ko9?BMNj?1JqѮAh$]]oL9 |mscsXKѩ]ǹ5 VSرrn_xiVrJEBR(=*yg/ t.H務0 a5 ŧ ̞oZQ=e_Pt10VӄL+4yr\RsTL<iP;>o_e҄Wa bEjiO0qoWbQVx\R-'gP,[D %%o= 6ײ~6XNYl;VMWzX乂6Ym{ %Xئݖ4xDD턁XexYīSTAz%X@eD Q]6yG =˲-dv]&%IIeHzIh&zOKE BD{w/3(eX$:4E H b(Fkgu;Sy6G0D# ̮fI>CB×I}D~hkA =@L ;%"Xf!1`Y{UfꕗU~5ΡtDĐ Ga8F8iʇ~"̠dJ ScHf"~ZYe7!R 23dN$ALYΥ7:@|J7=bDB8x%y? kB1hMJbOt\9_G:d_;^V+s*UcLË= 'Cۦ3Hm2Ԛ<~Q71d]> H~5=vVAtJHb@ITJ2y~c줌M8F%wW;ض@;޶@ lL S \)ҫ yhWV+HQQ$/^yQɯ(]@x0fDTu9qNGPB&cpxM/٤{^5i.#T\nƙ[V٥PqLܷCG!fjBd]0t˄-j4y0G 󷇧<+ ҫ̒EVj2v1Q#x\q4WM;s/כ J˞yȓ}kwФa?"2-ׂ'9A#fKy}&'aaYEZ9Į}?Fi*Wk,l,[8Fft})Bٮ'/z!jFO(Iq*J"ؿA]^osV ~ҢȌx*Wk>Dzͦjýeԍruc5:ѡ'@; $ll.dFL<Xӗ.eK;¶p8˧w45p68='txwц Š̀[yF0}%e-RѾL::ٝ4ׇײ`~mmyk:wQ9M4c/:ob=9j]|r65 gn)~چG u3 ] Oh陁I|)hDc3SYO w0ѡuR1B =AǍPGPY's4‰;#i%Qu e+oBn)gN;Fn&MC"PԺpKg /edPK~{kZŃcVBåoGwN :r][^Xqa"iQd- RW}m^Ԕvh ã<#VWz>*:D\Y$wp]b+#f4ři&9oAb=<;?ҝ&F4٧Dƕ6(%p o%4yO_r匒ej Bv5#`ތ:Mp<#{2ɕA`jj?[OG¦H#bfH|a26yqy3XL `"e/~'_Q;z%-oGP*:.K~WCxjVҧAlԗUק/2oߪ9BUޜGɼQi :ܔ5Fꓷ `.B~$+Ѡ̀u|KzzE–&uMzQ|bPAT2eeXadlV(@i$D-[[; #䉲#Z-E)0A&RB 5- 0[ /#"[?6]ԁg6"M޾k^{TQ_j\A>ԜZ[Ჺ2M Sq:EN\v) 0)AwRMR \\vt -LUL+ $MIK"a8Z ~O^ja/'.S, ʙP΅_y+/zfS]PRvz;@(%–OLwlS=ѯpIF!fhZF9 :9>V_~X!rZ7_dh 3xkO[_PMN|#Ǔ17&rآRE^o.Qx LSt[I/@T+"Z }36fMa2옓3*P#=u6@{Bi\wbgl:kJ0 +1<-qn1U=R:r߼uLdT`%4$B: yRH] Mz$Lڍ`@ޘѝF3-_,H?v ƕzi0lJ=ӱ_XM! uQG˥/7BcbΈ4j z3A |!vvv˚ HWJ<_@FE+dtJ.tA![D6g6c@M%la\^66OOoha԰aDTGi(4Y ^R$7acإo1`ϝg, 2hI<;K'Bw"= TB2ri$[H~r1] _!RS7?@I<~h8:^X$hjTr=BL?GUrf i)8ygIsRE֌kPO:xB5-Ϡ@/4Dcl8e pjs^1P LOQӢd4 %C3vҐaR;BmYY"-I5]h~-_ed\$MuI/G^ 5/^`R[TϼW ǘ5fBH#6`/\;h2~ޘOp CHwH &qgټm50n+@` z*t#}UeV'$Tه4'mbX7\4h`0}ǻe+c85N6YzTdA"T]@U!Uq]X@hֶ&z$!r;)+OhTUwF~e.˜J?;Ng +K%@fk8 UJgl*׈t^@A54F,`$o$8#\SOY؎崇aj6."aL}hn>^7}9b (. Qm![;M:&}"Z<cM&㉶YԆ)ǬCL"v'oc-NilևHwlbAZCϣclf8Kl'O&SՓ&G'?OɴO}dJט3ړܷIz㾆_XUzu|%2 A3!xp4. u/7̯!^^EEEEEEEEEEEa?."">>>>>Wx|x|x|x|x|x|x|x|8EEEE ӌËËËa{Wtaݻ7?|~ i ~3n>|w??????< c1 ?""pV-/?NËËËË$=EEEEFa???????;EEEEEEᇒfEEE_?=<1iPz#[r9+ckc%Tu[V[7S\s,qٚ2_'71k:sɰy\rXh1iLl/"3vLktr KKkk(j*^w@;ʳXxė5Z~jYA2w+/V$ZϿmA 0$81-/=PXVoqomaN)_f=1LDe9.PPkD{AI|}#' Mtb4|rDf@'_UʎBZ$ZUli1*IÙUX1'82$<<7-3W^Lvqaipmޫ~7SOVvV}m qU1*z'q8t<<=4pNTLcA+J Ss]f"~ZYU9^jAf2T֩`VYi곜K.RM.#4=;C_:]#8{u=Ox.KxS8@X.T&Ê圊*#bϳ3GIǠMgGX9񋺉'iFb jw_$qs1/{3dE2 ;`̎ ']87kέWd9 WJS1LR=HNԺ|O|m S\fӚ&rƷ : 3}.Pq3{hS5&J]Ei#@)qòI+oڱQ3_)>9{@ɟƌSet:x 7$i7JA'_CChVuyb'4MB0q/xu^ hxp;YNvT% K N jV_F/7Gwզ:p83 > HޕM()z{1D{ihQ'Z53Gt*vc#7bHg5Cz]6Lzv>&P\!kCCTGa1 Smi?Fȗv>> Oc{Wbs:9_Z?h:oc$"ǿ9[ `!c&l9 7H FDQG -B"1qDx8#qGpyR3` :cs(+я[͎4^xs>ұOJ "z]Gg/U@ A=0fIo|LtDzE̛+,~tzGiwCːŻݿw; :[h(h@)jtN F#(|vb˼43`W'+%q&~En3;̏9 4V+>e\:,/yG1 LVԶ;Ib ,zFMv8Bf>=QP?ۆ-ێA͵ [& v8́*$]K,S2-U}'Oa h :.z^]<gI϶piBGf݆G\ĸDQoY2@c.;ߨ&a`GE_MyRů~x%iaa%IwK:OBO\`GJeAƊhAqHjy3x#!JiK;hh=PK4 ,%hz6\ s>B_<7X2>I"I9"Nd6؎-LtݛT}Bvj0ܔ#Y*S dL债 0v\s6 URhWՉp$u<́E"=n0ՓuxpwUzoW_??6+oկao7`Yai47 eqy ~zs_14{7>t{~>*P?[65>6srqUO ԰W0_q)-ޙW2a?i=ޖy]h/0~Fb N4u ʹW@+_= d҅D <=ǠVAUzK+iUx•mouKzCc x kNX9}஺ᣤH-͎7"5 2HbmmRUx=ܚdϡ5F`RZ ܳxHl M#~.s A,԰ l!=l1H/ӡ<&Ю75'M5ǒs!}xm{,=B5{ѰIC\H\3€ؚîV2[R! uL>{%SKo^=cI״GiѼ2Eߔ#P4a.WJ[cu0.@IݦI;6Ә섘DLRT4)/ɀX7Nq K}r9Q_t+LҒ$hCr_B%7/Gf_gB&@ G__y~o;.v1$ް5ʅ=/t5 '2r'G@^mz c iЍ6+AM4J x)t&c>vxD36oҲ Yiw:pR>>Vz'o3h@H6cws,pN`/`\㟯w2ixC>@+όSDAr36E^^o(Y>H^6+#YrTR״4}]8+R%rb6tuz>:;] >?=uQZ>g `G,o씘/܍8}k5w&Nn`-QcqAPD*p'>*܄e׸G ZrmyT]H38UÖWx5Rx2BHh @QC?'T&:1kՎ,lbsҷKA2$mnKxK$1,E&h&ͤ?p7Qq:ϿBPDQ?mmAH5? fv=U'h y+Guȏs%<`^~P`0 KQ*G~狟n_8/~͏ϟz_Z 2<*'ap tД# $/'~s6}s}X4Mii~ FZ5M{[|O"2jYQl?;n4otWэ?꺅huQLu ȵ#MQ'GOZw[ :G}5BwAOБQ`DCw(_ ,  AddhsPDq8 @gӅe-uimzB${dv)B;[i⛽3i*J$P~~&^AC'fQtm&hLo)5c ڡwHAM]"ْ.+Q>2˸D̎)-[֬0J2=6uV9:ގc>(>=y/0)5ɿ2H9/FAn;I4,p @-ٞAsа :NC67:ik"0p2+kFl]#L